HPV Awareness and Vaccine Acceptability in Hispanic Women Living Along the US-Mexico Border

Overview

Journal J Immigr Minor Health

Publisher Springer

Specialties Public Health
Social Sciences

Date 2013 Jun 14

PMID 23760806

Citations 9

Authors

Jennifer Molokwu

Norma P Fernandez

Charmaine Martin

Affiliations

Soon will be listed here.

Abstract

Despite advances in prevention of cervical cancer in the US, women of Hispanic origin still bear an unequal burden in cervical cancer incidence, morbidity and mortality. Our objective was to determine the HPV vaccine knowledge and acceptability in a group of mostly Hispanic females. In this cross sectional survey, 62 % of participants heard of HPV; 34.9 % identified HPV as a cause of cervical cancer. 63 % of participants reported willingness to receive vaccine and 77 % were willing to vaccinate daughters. Those with previous abnormal PAPs were more likely to have heard of HPV and Vaccine. No other factors examined showed association with willingness to get vaccine or administer to daughters. Knowledge level remains low in this high risk population. Willingness to receive vaccine is high despite lack of access to care. Increased targeted community based education and vaccination programs may be useful in closing disparity in cervical cancer morbidity.

Citing Articles

Changes in Cancer Screening Knowledge Among a Prospective Cohort of Spanish-Speaking Hispanic Community Outreach Event Participants in Florida and Puerto Rico.

Christy S, Castro-Figueroa E, Lopez J, Sutton S, McIntyre M, Garcia J J Cancer Educ. 2023; 39(1):18-26.

PMID: 37702848 PMC: 11190955. DOI: 10.1007/s13187-023-02368-8.

HPV Vaccine Beliefs and Correlates of Uptake Among Hispanic Women and Their Children on the US-Mexico Border.

Calderon-Mora J, Ferdous T, Shokar N Cancer Control. 2020; 27(1):1073274820968881.

PMID: 33121254 PMC: 7791461. DOI: 10.1177/1073274820968881.

Barriers and Facilitators to Breast and Cervical Cancer Screening Among Immigrants in the United States.

Adunlin G, Cyrus J, Asare M, Sabik L J Immigr Minor Health. 2018; 21(3):606-658.

PMID: 30117005 DOI: 10.1007/s10903-018-0794-6.

Social Determinants of Sexual Behavior and Awareness of Sexually Transmitted Infections (STI) Among Low-Income HIV+ or STI At-Risk Hispanic Residents Receiving Care at the U.S.-Mexico Border.

Tabler J, Mykyta L, Schmitz R, Kamimura A, Martinez D, Martinez R J Community Health. 2018; 44(1):127-136.

PMID: 30094723 DOI: 10.1007/s10900-018-0562-5.

HPV Knowledge and Vaccine Initiation Among Mexican-Born Farmworkers in North Carolina.

Furgurson K, Sandberg J, Hsu F, Mora D, Quandt S, Arcury T Health Promot Pract. 2018; 20(3):445-454.

PMID: 29597873 PMC: 6237648. DOI: 10.1177/1524839918764671.

References

Weinstock H, Berman S, Cates Jr W . Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004; 36(1):6-10. DOI: 10.1363/psrh.36.6.04. View

Constantine N, Jerman P . Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007; 40(2):108-15. DOI: 10.1016/j.jadohealth.2006.10.007. View

Gottlieb S, Brewer N, Sternberg M, Smith J, Ziarnowski K, Liddon N . Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009; 45(5):430-7. DOI: 10.1016/j.jadohealth.2009.03.029. View

Szarewski A, Poppe W, Skinner S, Wheeler C, Paavonen J, Naud P . Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer. 2011; 131(1):106-16. DOI: 10.1002/ijc.26362. View

Waller P, Crow C, Sands D, Becker H . Health related attitudes and health promoting behaviors: differences between health fair attenders and a community group. Am J Health Promot. 1989; 3(1):17-23, 32. DOI: 10.4278/0890-1171-3.1.17. View

Kahn J, Ding L, Huang B, Zimet G, Rosenthal S, Frazier A . Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009; 123(6):1439-45. DOI: 10.1542/peds.2008-1536. View

Dempsey A, Zimet G, Davis R, Koutsky L . Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006; 117(5):1486-93. DOI: 10.1542/peds.2005-1381. View

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. DOI: 10.3322/caac.20121. View

Manhart L, Burgess-Hull A, Fleming C, Bailey J, Haggerty K, Catalano R . HPV vaccination among a community sample of young adult women. Vaccine. 2011; 29(32):5238-44. PMC: 3138805. DOI: 10.1016/j.vaccine.2011.05.024. View

10.

Shen-Gunther J, Shank J, Ta V . Gardasil™ HPV vaccination: surveillance of vaccine usage and adherence in a military population. Gynecol Oncol. 2011; 123(2):272-7. DOI: 10.1016/j.ygyno.2011.07.094. View

11.

. National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60(33):1117-23. View

12.

Kahn J, Hillard P . Human papillomavirus and cervical cytology in adolescents. Adolesc Med Clin. 2004; 15(2):301-21, ix. DOI: 10.1016/j.admecli.2004.03.001. View

13.

Kobetz E, Kornfeld J, Vanderpool R, Finney Rutten L, Parekh N, OBryan G . Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010; 15 Suppl 3:22-9. PMC: 3858859. DOI: 10.1080/10810730.2010.522695. View

14.

de Sanjose S, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B . Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8. View

15.

Davis K, Dickman E, Ferris D, Dias J . Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2005; 8(3):188-94. DOI: 10.1097/00128360-200407000-00005. View

16.

Sanderson M, Coker A, Eggleston K, Fernandez M, Arrastia C, Fadden M . HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt). 2009; 18(11):1793-9. PMC: 2828161. DOI: 10.1089/jwh.2008.1266. View

17.

Munoz N, Bosch F, de Sanjose S, Herrero R, Castellsague X, Shah K . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27. DOI: 10.1056/NEJMoa021641. View

18.

Paavonen J, Jenkins D, Bosch F, Naud P, Salmeron J, Wheeler C . Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007; 369(9580):2161-2170. DOI: 10.1016/S0140-6736(07)60946-5. View

19.

Lu B, Kumar A, Castellsague X, Giuliano A . Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011; 11:13. PMC: 3034689. DOI: 10.1186/1471-2334-11-13. View

20.

Mays R, Sturm L, Zimet G . Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004; 58(7):1405-13. DOI: 10.1016/S0277-9536(03)00335-6. View